Options for successful renal transplantation in recipients with incompatible living donors: Severance Hospital experience.

Kyu Ha Huh, Myoung Soo Kim, Yu Seun Kim, Hyun Jung Kim, Hae Jin Kim, Hyun Ok Kim, Tae Hyun Yoo, Soon Il Kim, Kiil Park

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Exchange donor programs and desensitization protocols are available options for ABO-incompatible and positive cross-match living donor kidney transplantations. Patient and donor blood types, the degree of sensitization, and DSA titers should be considered to achieve successful kidney transplantation in recipients with incompatible living donors. Highly sensitized blood type O patients with ABO-incompatible living donors, or highly sensitized patients with a positive cross-match (with low DSA titer) to their AB donors should be considered for a desensitization protocol as a first priority. Narrowly sensitized patients with a positive cross-match (and high DSA titer) should be considered for an exchange donor program if possible. Patients with positive cross-match O donors can be easily matched and benefit from an exchange program. Exchange donor programs and desensitization protocols are complementary strategies to overcome HLA and ABO antibody barriers.

Original languageEnglish
Pages (from-to)323-326
Number of pages4
JournalClinical transplants
Publication statusPublished - 2010 Dec 1

Fingerprint

Living Donors
Kidney Transplantation
Tissue Donors
Blood Donors
Antibodies

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Huh, Kyu Ha ; Kim, Myoung Soo ; Kim, Yu Seun ; Kim, Hyun Jung ; Kim, Hae Jin ; Kim, Hyun Ok ; Yoo, Tae Hyun ; Kim, Soon Il ; Park, Kiil. / Options for successful renal transplantation in recipients with incompatible living donors : Severance Hospital experience. In: Clinical transplants. 2010 ; pp. 323-326.
@article{80c81a19de954a0bb480fd638d9ad849,
title = "Options for successful renal transplantation in recipients with incompatible living donors: Severance Hospital experience.",
abstract = "Exchange donor programs and desensitization protocols are available options for ABO-incompatible and positive cross-match living donor kidney transplantations. Patient and donor blood types, the degree of sensitization, and DSA titers should be considered to achieve successful kidney transplantation in recipients with incompatible living donors. Highly sensitized blood type O patients with ABO-incompatible living donors, or highly sensitized patients with a positive cross-match (with low DSA titer) to their AB donors should be considered for a desensitization protocol as a first priority. Narrowly sensitized patients with a positive cross-match (and high DSA titer) should be considered for an exchange donor program if possible. Patients with positive cross-match O donors can be easily matched and benefit from an exchange program. Exchange donor programs and desensitization protocols are complementary strategies to overcome HLA and ABO antibody barriers.",
author = "Huh, {Kyu Ha} and Kim, {Myoung Soo} and Kim, {Yu Seun} and Kim, {Hyun Jung} and Kim, {Hae Jin} and Kim, {Hyun Ok} and Yoo, {Tae Hyun} and Kim, {Soon Il} and Kiil Park",
year = "2010",
month = "12",
day = "1",
language = "English",
pages = "323--326",
journal = "Clinical transplants",
issn = "0890-9016",
publisher = "UCLA Immunogenetics Center",

}

Options for successful renal transplantation in recipients with incompatible living donors : Severance Hospital experience. / Huh, Kyu Ha; Kim, Myoung Soo; Kim, Yu Seun; Kim, Hyun Jung; Kim, Hae Jin; Kim, Hyun Ok; Yoo, Tae Hyun; Kim, Soon Il; Park, Kiil.

In: Clinical transplants, 01.12.2010, p. 323-326.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Options for successful renal transplantation in recipients with incompatible living donors

T2 - Severance Hospital experience.

AU - Huh, Kyu Ha

AU - Kim, Myoung Soo

AU - Kim, Yu Seun

AU - Kim, Hyun Jung

AU - Kim, Hae Jin

AU - Kim, Hyun Ok

AU - Yoo, Tae Hyun

AU - Kim, Soon Il

AU - Park, Kiil

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Exchange donor programs and desensitization protocols are available options for ABO-incompatible and positive cross-match living donor kidney transplantations. Patient and donor blood types, the degree of sensitization, and DSA titers should be considered to achieve successful kidney transplantation in recipients with incompatible living donors. Highly sensitized blood type O patients with ABO-incompatible living donors, or highly sensitized patients with a positive cross-match (with low DSA titer) to their AB donors should be considered for a desensitization protocol as a first priority. Narrowly sensitized patients with a positive cross-match (and high DSA titer) should be considered for an exchange donor program if possible. Patients with positive cross-match O donors can be easily matched and benefit from an exchange program. Exchange donor programs and desensitization protocols are complementary strategies to overcome HLA and ABO antibody barriers.

AB - Exchange donor programs and desensitization protocols are available options for ABO-incompatible and positive cross-match living donor kidney transplantations. Patient and donor blood types, the degree of sensitization, and DSA titers should be considered to achieve successful kidney transplantation in recipients with incompatible living donors. Highly sensitized blood type O patients with ABO-incompatible living donors, or highly sensitized patients with a positive cross-match (with low DSA titer) to their AB donors should be considered for a desensitization protocol as a first priority. Narrowly sensitized patients with a positive cross-match (and high DSA titer) should be considered for an exchange donor program if possible. Patients with positive cross-match O donors can be easily matched and benefit from an exchange program. Exchange donor programs and desensitization protocols are complementary strategies to overcome HLA and ABO antibody barriers.

UR - http://www.scopus.com/inward/record.url?scp=79960068262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960068262&partnerID=8YFLogxK

M3 - Article

C2 - 21698836

AN - SCOPUS:79960068262

SP - 323

EP - 326

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -